Nature Podcast cover image

Audio long-read: The quest to prevent MS — and understand other post-viral diseases

Nature Podcast

CHAPTER

E B v Vaccines Can Prevent Infectious Mono Nucleosis

The aim of the first trials will be to show that these vaccine candidates are safe and can reduce the burden of infectious mono nucleosis. This illness causes symptoms including extreme fatigue and fever, and affects 30 to 50 % of people who contract e b v for the first time as teen ages or young adults. On average it takes around ten years for a vaccine to run the clinical trial gauntlet. After approval, observational data would take many more years to accumulate.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner